These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21398121)

  • 41. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
    Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
    Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.
    Barter PJ; Kastelein JJ
    J Am Coll Cardiol; 2006 Feb; 47(3):492-9. PubMed ID: 16458126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL.
    Yvan-Charvet L; Matsuura F; Wang N; Bamberger MJ; Nguyen T; Rinninger F; Jiang XC; Shear CL; Tall AR
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1132-8. PubMed ID: 17322101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Future of cholesteryl ester transfer protein inhibitors.
    Rader DJ; deGoma EM
    Annu Rev Med; 2014; 65():385-403. PubMed ID: 24422575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
    Tall A; Sammett D; Granot E
    J Clin Invest; 1986 Apr; 77(4):1163-72. PubMed ID: 3958185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.
    Gautier T; Masson D; Jong MC; Pais de Barros JP; Duverneuil L; Le Guern N; Deckert V; Dumont L; Bataille A; Zak Z; Jiang XC; Havekes LM; Lagrost L
    Biochem J; 2005 Jan; 385(Pt 1):189-95. PubMed ID: 15339254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
    Atger V; de la Llera Moya M; Bamberger M; Francone O; Cosgrove P; Tall A; Walsh A; Moatti N; Rothblat G
    J Clin Invest; 1995 Dec; 96(6):2613-22. PubMed ID: 8675626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and synthesis of 2-substituted benzoxazoles as novel PTP1B inhibitors.
    Chandrasekharappa AP; Badiger SE; Dubey PK; Panigrahi SK; Manukonda SR
    Bioorg Med Chem Lett; 2013 May; 23(9):2579-84. PubMed ID: 23528300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein.
    Reinhard EJ; Wang JL; Durley RC; Fobian YM; Grapperhaus ML; Hickory BS; Massa MA; Norton MB; Promo MA; Tollefson MB; Vernier WF; Connolly DT; Witherbee BJ; Melton MA; Regina KJ; Smith ME; Sikorski JA
    J Med Chem; 2003 May; 46(11):2152-68. PubMed ID: 12747787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design and synthesis of benzoxazole containing indole analogs as peroxisome proliferator-activated receptor-γ/δ dual agonists.
    Gim HJ; Cheon YJ; Ryu JH; Jeon R
    Bioorg Med Chem Lett; 2011 May; 21(10):3057-61. PubMed ID: 21482466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholesteryl ester transfer protein (CETP) inhibitors: is there life after torcetrapib?
    Neeli H; Rader DJ
    Cardiol Clin; 2008 Nov; 26(4):537-46. PubMed ID: 18929230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitors.
    Costales A; Mathur M; Ramurthy S; Lan J; Subramanian S; Jain R; Atallah G; Setti L; Lindvall M; Appleton BA; Ornelas E; Feucht P; Warne B; Doyle L; Basham SE; Aronchik I; Jefferson AB; Shafer CM
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1592-6. PubMed ID: 24534486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors.
    Cho SY; Han SY; Ha JD; Ryu JW; Lee CO; Jung H; Kang NS; Kim HR; Koh JS; Lee J
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4223-7. PubMed ID: 20570511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of benzoxazole analogs as novel, S1P(3) sparing S1P(1) agonists.
    Deng G; Meng Q; Liu Q; Xu X; Xu Q; Ren F; Guo TB; Lu H; Xiang JN; Elliott JD; Lin X
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3973-7. PubMed ID: 22583616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of Various 2-Aminobenzoxazoles: The Study of Cyclization and Smiles Rearrangement.
    Šlachtová V; Chasák J; Brulíková L
    ACS Omega; 2019 Nov; 4(21):19314-19323. PubMed ID: 31763555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of ligand efficiency metrics in drug discovery.
    Hopkins AL; Keserü GM; Leeson PD; Rees DC; Reynolds CH
    Nat Rev Drug Discov; 2014 Feb; 13(2):105-21. PubMed ID: 24481311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: attenuation of hERG binding and improved HDLc-raising efficacy.
    Sweis RF; Hunt JA; Sinclair PJ; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Cumiskey AM; Latham M; Rosa R; Peterson L; Sparrow CP; Anderson MS
    Bioorg Med Chem Lett; 2011 May; 21(9):2597-600. PubMed ID: 21398121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2-(4-carbonylphenyl)benzoxazole inhibitors of CETP: scaffold design and advancement in HDLc-raising efficacy.
    Sweis RF; Hunt JA; Kallashi F; Hammond ML; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Cumiskey AM; Latham M; Rosa R; Peterson L; Sparrow CP; Wright SD; Anderson MS; Sinclair PJ
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1890-5. PubMed ID: 21147531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.